Estrogen-Alone Therapy There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens (5.2) The Womens Health Initiative (WHI) estrogen-alone substudy reported increased risks of stroke and deep vein thrombosis (DVT) (5.1) The WHI Memory Study (WHIMS) estrogen-alone ancillary study of WHI reported an increased risk of developing probable dementia in postmenopausal women 65 years of age and older (5.3) Do not use estrogen-alone therapy for the prevention of cardiovascular disease or dementia (5.1, 5.3) Estrogen Plus Progestin Therapy The WHI estrogen plus progestin substudy reported increased risks of DVT, pulmonary embolism (PE), stroke and myocardial infarction (MI) (5.1) The WHI estrogen plus progestin substudy reported increased risks of invasive breast cancer (5.2) The WHIMS estrogen plus progestin ancillary study of WHI reported an increased risk of developing probable dementia in postmenopausal women 65 years of age and older (5.3) Do not use estrogen plus progestogen therapy for the prevention of cardiovascular disease or dementia (5.1, 5.3) Recent Major Changes Warnings and Precautions, Malignant Neoplasms (5.2) 11/2023 Indications and Usage for Vivelle-Dot Vivelle-Dot is an estrogen indicated for: Treatment of moderate to severe vasomotor symptoms due to menopause (1.1) Treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause (1.2) Limitations of Use When prescribing solely for the treatment of moderate to severe vaginal atrophy, first consider the use of topical vaginal products

In preclinical animal studies, BPC 157 has shown a very high safety profile with no significant adverse effects reported
January 27, 2024 Is Protein Powder Ultra-Processed
Contact Us Tirzepatide Powder represents a paradigm shift in the management of diabetes and obesity, offering unparalleled efficacy through its dual GIP/GLP-1 receptor agonism
These approaches have strong safety data in women planning pregnancy and can help prevent excessive weight regain during the transition off medication